Chemical Component Summary

Name3-{2,4-dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
SynonymsSU6668
Identifiers3-[2,4-dimethyl-5-[(Z)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid
FormulaC18 H18 N2 O3
Molecular Weight310.347
TypeNON-POLYMER
Isomeric SMILESCc1c(c([nH]c1/C=C\2/c3ccccc3NC2=O)C)CCC(=O)O
InChIInChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-
InChIKeyNHFDRBXTEDBWCZ-ZROIWOOFSA-N

Chemical Details

Formal Charge0
Atom Count41
Chiral Atom Count0
Bond Count43
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB12072 
NameOrantinib
Groups investigational
DescriptionOrantinib has been used in trials studying the treatment of Lung Cancer, Breast Cancer, Kidney Cancer, Gastric Cancer, and Prostate Cancer, among others.
Synonyms
  • Orantinib
  • Orantinibum
Categories
  • Acids, Acyclic
  • Alkaloids
  • Enzyme Inhibitors
  • Fatty Acids
  • Fatty Acids, Volatile
CAS number252916-29-3

Related Resource References

Resource NameReference
Pharos CHEMBL274654
PubChem 5329099
ChEMBL CHEMBL274654